arrow
D

Dmitry Enikeev

Sechenov University
H指数:37
被引数:4,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathological assessment of morcellated tissue after ERBT: insights from a two-round Delphi survey

经内镜肾部分切除术(ERBT)后组织切碎物的病理评估:两轮德尔菲调查的见解

2026-05-080
OAAI
Machine learning models to predict postoperative incontinence after endoscopic enucleation of the prostate for benign prostatic hyperplasia: An EAU-Endourology study

用于预测良性前列腺增生经内镜剜除术后术后尿失禁的机器学习模型:一项EAU-Endourology研究

2025-08-190
PRE
Modeling of phosphorylated forms of complement system factors C4 and CFB

C4和CFB补体系统因子的磷酸化形式建模

2025-06-300
PRE
The Role of Morcellation in En Bloc Resection of Large Bladder Tumors

粉碎术在大膀胱肿瘤整块切除术中的作用

2025-03-130
OAAI
Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515
2024-08-010
PRE
Laser Ablation Efficiency, Laser Ablation Speed, and Laser Energy Consumption During Lithotripsy: What Are They and How Are They Defined? A Systematic Review and Proposal for a Standardized Terminology
2024-07-0112
OAAI
Prospective non-randomized comparison of transurethral laser en bloc resection vs. conventional resection of bladder tumors larger than 3 cm

经尿道激光整块切除术与常规切除术治疗大于3厘米的膀胱肿瘤的前瞻性非随机比较

2024-07-011
PRE
Global burden, risk factors, and temporal trends of ureteral cancer: a comprehensive analysis of cancer registries

输尿管癌的全球负担,危险因素和时间趋势: 癌症登记的综合分析

2024-06-240
OAAI
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder Cancer
2024-06-012
PRE
Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15 Reply
2024-06-010
OA